California Public Employees Retirement System Adma Biologics, Inc. Transaction History

California Public Employees Retirement System

  • $147 Billion
  • Q4 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021
SELL
$1.51 - $2.07 $240,241 - $329,337
-159,100 Closed
0 $0
Q4 2020

Feb 02, 2021
SELL
$1.8 - $2.56 $5,940 - $8,448
-3,300 Reduced 2.03%
159,100 $310,000
Q3 2020

Nov 05, 2020
SELL
$2.04 - $3.74 $16,183 - $29,669
-7,933 Reduced 4.66%
162,400 $388,000
Q2 2020

Aug 12, 2020
BUY
$2.42 - $3.29 $198,803 - $270,273
82,150 Added 93.16%
170,333 $499,000
Q4 2019

Jan 27, 2020
BUY
$3.89 - $5.15 $343,031 - $454,142
88,183 New
88,183 $353,000

Others Institutions Holding ADMA

# of Institutions
346
Shares Held
181M
Call Options Held
1.72M
Put Options Held
846K
View Full List

About ADMA BIOLOGICS, INC.

ADMA Quotes by TradingView
  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.86B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email